KonsultaMD has introduced a new diabetes screening package priced at P499 to address the growing prevalence of diabetes in the Philippines. The package includes a Fasting Blood Sugar test and a video consultation with a general practitioner.
Diabetes, the fourth leading cause of death in the Philippines, affects approximately 1 in 14 adults, according to government statistics. Many individuals remain asymptomatic for 5 to 7 years before being diagnosed, highlighting the importance of early screening. KonsultaMD’s package aims to facilitate timely detection and prevention of the disease.
The condition predominantly affects those who are overweight, smoke, consume alcohol regularly, have a family history of diabetes, or show signs of insulin resistance.
Beia Latay, CEO of KonsultaMD, emphasized the company’s commitment to improving public health.
“Our goal is to empower Filipinos to take charge of their health. By offering an affordable and convenient diabetes screening package, we’re making it easier for individuals to invest in their well-being and potentially detect diabetes in its early stages,” she said.
The screening process is streamlined through the KonsultaMD app, allowing users to schedule their Fasting Blood Sugar test with a partner diagnostic laboratory and consult with a general practitioner available 24/7.
This initiative supports KonsultaMD’s mission to enhance healthcare access in the Philippines. As a portfolio company of 917Ventures, a wholly-owned subsidiary of Globe, KonsultaMD provides comprehensive telehealth services, including 24/7 doctor access, medical certificates, same-day pharmacy delivery, at-home diagnostics, and nursing care.
Filipinos can access the new screening package by visiting https://konsulta.md or downloading the app from the App Store or Google Play.
